We strive to stay at the forefront of biotechnological developments and to constantly incorporate innovation in our offerings – this is essential to be able to develop more reliable drug development platforms and avoid high drug attrition rates.
Study director Immuno-oncology Kim Frederix and BDM Pascal Simoens will have the opportunity to discuss the importance of innovation in attaining a #smartroadtoabetterhealth at the SINERGIA summer school in June 14.
Our Innovative Projects
PDX/O Oncology Platform
InnoSer has many collaborative projects with research groups from both academia and industry settings to develop novel technologies for use in preclinical settings. This includes a project executed in partnership with Vrije Universiteit Brussel and in close collaboration with Jessa Hospital in Hasselt, Belgium, and Leiden University Medical Center (LUMC, the Netherlands) that resulted in the development of an integrated PDXO drug screening platform. This platform consists of two complementary components, patient-derived xenografts (PDX) and patient-derived organoids (PDO), which are characterized in the same manner. Such models resemble the original patient-derived tumour both phenotypically and genetically. For this reason, one of the main advantages of such a platform is its predictive value in drug screening, as your compounds can be coherently tested both in vitro and in vivo, using the same starting parental material.
Many xenografts, organoids or combined models are already validated and currently available for compound testing. For other models, we are happy to collaborate and validate the platform with your compounds.
We have many other ongoing international collaborations in order to support, develop and actively invest in more effective platforms for drug development to contribute to scientific advancements. Curious about the projects we are currently involved in?
Check out the overview of InnoSer’s consortia projects that include development of organoid and organ-on-chip platforms. Curious and would you like to get in touch?
Want to read more?
Animal testing has played a critical role in the development of drugs, enabling us to ultimately obtain data which serves as a foundation to be able to deliver safe and effective drugs to patients. We are an AAALAC accredited organization committed to the 3Rs, by...
We are constantly looking for opportunities to exchange and develop ideas, as they are the foundation for scientific advances and innovation. In addition to our collaboration with academic and commercial partners, attending conferences such as Knowledge for Growth...
We are eager to join the Dutch life sciences conference - a great opportunity for high-quality networking with many start-up companies, service providers, and research organisations. This year we are happy to be showcasing our novel InnoSer Acceleration Program (ISAP)...